| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |